Approval · Notice of Compliance 10863 · 2009
3TC: Notice of Compliance 10863
Issued December 15, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10863
- Date
- December 15, 2009
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiretroviral agent
Products in this notice
Medicinal ingredients
- LAMIVUDINE 10 MG per ML
- LAMIVUDINE 150 MG per TAB
- LAMIVUDINE 300 MG per TAB